An expert review report released by the Food and Drug Administration (FDA) Monday raised doubts as to whether the vaccine developed by Taiwan-based United Biomedical Inc. (UBI) Asia offers sufficient protection against COVID-19 variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Warm spell forecast to end Sunday as cold front arrives in Taiwan
02/15/2025 09:32 PM - Politics
Huang Kuo-chang elected TPP chairman until December 2026
02/15/2025 08:54 PM - Society
Man recalls frantic drive to save toddler hurt in Taichung blast
02/15/2025 07:58 PM - Society
Taichung mall offers families of blast victims NT$11 million each
02/15/2025 07:04 PM - Business
TSMC top patent applicant in Taiwan for 9th straight year
02/15/2025 05:47 PM